Artwork

Content provided by The Atlantic Monthly Group, LLC and The Atlantic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Atlantic Monthly Group, LLC and The Atlantic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Share the Vaccine 'Recipe'

34:42
 
Share
 

Manage episode 292365557 series 2649045
Content provided by The Atlantic Monthly Group, LLC and The Atlantic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Atlantic Monthly Group, LLC and The Atlantic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

When the Biden administration announced support for waiving COVID vaccine patents last week, it was met with praise, relief, skepticism, and alarm among different groups—but surprise all around. Pharmaceutical giants have long fought efforts to have their intellectual property released to meet international needs. And they’ve backed it up with immense political muscle. Could this time be different? Would it disincentivize future research, as critics like Bill Gates claim? And how much (and how quickly) could it help?

To understand the issue, Jim and Maeve are joined by Julie Rovner, the Chief Washington Correspondent for Kaiser Health News and host of the podcast “What The Health?”

Support this show and all of The Atlantic’s journalism by becoming a subscriber at theatlantic.com/supportus.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

124 episodes

Artwork

Share the Vaccine 'Recipe'

Social Distance

108 subscribers

published

iconShare
 
Manage episode 292365557 series 2649045
Content provided by The Atlantic Monthly Group, LLC and The Atlantic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Atlantic Monthly Group, LLC and The Atlantic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

When the Biden administration announced support for waiving COVID vaccine patents last week, it was met with praise, relief, skepticism, and alarm among different groups—but surprise all around. Pharmaceutical giants have long fought efforts to have their intellectual property released to meet international needs. And they’ve backed it up with immense political muscle. Could this time be different? Would it disincentivize future research, as critics like Bill Gates claim? And how much (and how quickly) could it help?

To understand the issue, Jim and Maeve are joined by Julie Rovner, the Chief Washington Correspondent for Kaiser Health News and host of the podcast “What The Health?”

Support this show and all of The Atlantic’s journalism by becoming a subscriber at theatlantic.com/supportus.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

124 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide